Immediate Impact
8 standout
Citing Papers
Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
2024 Standout
Lung cancer immunotherapy: progress, pitfalls, and promises
2023 Standout
Works of Stefanie Veit being referenced
Does Dose Matter? Effect of Two Different Neoadjuvant Protocols in Advanced NSCLC
2012
Trimodal Therapy for Histologically Proven N2/3 Non–Small Cell Lung Cancer: Mid-Term Results and Indicators for Survival
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Stefanie Veit | 121 | 49 | 27 | 28 | 15 | 159 | |
| Rossella Potenza | 169 | 24 | 89 | 29 | 16 | 232 | |
| Juan Pablo Sade | 50 | 28 | 15 | 24 | 16 | 88 | |
| G. Salvi | 51 | 38 | 31 | 17 | 20 | 96 | |
| Marco Banini | 91 | 101 | 25 | 13 | 14 | 156 | |
| Adam Peryt | 117 | 17 | 55 | 46 | 21 | 188 | |
| G. Béra | 73 | 41 | 28 | 47 | 16 | 154 | |
| Shohei Mori | 80 | 40 | 24 | 12 | 21 | 173 | |
| J.A. Messer | 64 | 50 | 23 | 64 | 17 | 158 | |
| G. E. Flatman | 47 | 39 | 55 | 16 | 11 | 163 | |
| György Szabó | 42 | 26 | 90 | 35 | 18 | 170 |
All Works
Loading papers...